TGF-β promotes ECM deposition, or selectively inhibits collagenase synthesis, induces the production of collagenase inhibitors or inhibits the expression and activation of protease inhibitors, and ultimately reduces collagen degradation, thus effectively promoting the formation of ECM-mediated pulmonary fibrosis [43]. This evidence concerns the gene TGFB1 and pulmonary fibrosis.